Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer
- Roca, J.-M.
- Alonso, V.
- Pericay, C.
- Escudero, P.
- Salud, A.
- Losa, F.
- López, L.-J.
- Guasch, I.
- Méndez, M.
- Quintero-Aldana, G.
- Grande, C.
- Vicente, P.
- Arrivi, A.
- Martin, C.
- Moreno, I.
- García, P.
- Antón, I.
- Constenla, M.
- Yubero, A.
- Cirera, L.
ISSN: 0009-3157
Argitalpen urtea: 2010
Alea: 56
Zenbakia: 2
Orrialdeak: 142-146
Mota: Artikulua